RAFFA WEALTH MANAGEMENT, LLC’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Buy
57
+4
+8% +$765 ﹤0.01% 382
2026
Q1
$9.72K Buy
53
+2
+4% +$369 ﹤0.01% 400
2025
Q4
$8.97K Buy
51
+16
+46% +$2.61K ﹤0.01% 393
2025
Q3
$4.9K Buy
35
+14
+67% +$1.89K ﹤0.01% 491
2025
Q2
$2.64K Hold
21
﹤0.01% 631
2025
Q1
$2.87K Sell
21
-4
-16% -$572 ﹤0.01% 548
2024
Q4
$3.82K Hold
25
﹤0.01% 504
2024
Q3
$4.85K Hold
25
﹤0.01% 424
2024
Q2
$5.8K Hold
25
﹤0.01% 522
2024
Q1
$5.39K Buy
+25
New +$5.86K ﹤0.01% 496
2023
Q3
$7.97K Buy
+31
New +$8.29K ﹤0.01% 309
2022
Q4
$8.59K Hold
31
﹤0.01% 305
2022
Q3
$8.28K Buy
+31
New +$6.58K ﹤0.01% 301
2021
Q4
$7.44K Hold
31
﹤0.01% 348
2021
Q3
$8.77K Hold
31
﹤0.01% 279
2021
Q2
$10.7K Buy
+31
New +$9.39K ﹤0.01% 257
2020
Q4
$6.37K Buy
+26
New +$6.71K ﹤0.01% 317
2020
Q2
$5.89K Hold
22
﹤0.01% 289
2020
Q1
$6.96K Buy
+22
New +$6.68K ﹤0.01% 236
2019
Q3
$3.73K Buy
+16
New +$3.73K ﹤0.01% 303
2018
Q1
$4.38K Buy
+16
New +$4.97K ﹤0.01% 256
2016
Q3
$1.56K Buy
+5
New +$1.48K ﹤0.01% 315
2016
Q1
$1.3K Hold
5
﹤0.01% 337
2015
Q4
$1.53K Buy
+5
New +$1.44K ﹤0.01% 298
2015
Q2
$2.02K Hold
5
﹤0.01% 274
2015
Q1
$2.11K Hold
5
﹤0.01% 261
2014
Q4
$1.7K Hold
5
﹤0.01% 268
2014
Q3
$1.65K Buy
+5
New +$1.65K ﹤0.01% 273
2014
Q1
Sell
-5
Closed -$1.7K 326
2013
Q4
$1.7K Buy
+5
New +$1.29K ﹤0.01% 268

Other funds holding BIIB

RAFFA WEALTH MANAGEMENT, LLC's BIIB Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Biogen (BIIB) stake by 7.5% in Q2 2026, buying an estimated $765 and bringing the position to 57 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #382.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in BIIB in Q4 2013 and has held it in 29 quarters since. 301 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 57 shares of Biogen worth $12.3K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 4 Biogen shares in Q2 2026, an estimated $765.
  • Biogen made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #382 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Biogen in Q4 2013 and has held it in 29 quarters since.
  • 301 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.